Nasal Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy (NCT01891123) | Sun Yat-sen University | 2013-06-01 |
Track Nasal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.